Denosumab For The Treatment Of Bisphosphonate-Refractory Hypercalcemia Of Malignancy - A Case Report

Journal Title: Journal of Medical Sciences - Year 2015, Vol 18, Issue 2

Abstract

Hypercalcemia of malignancy caused primarily by tumor-induced bone resorption may lead to renal failure, coma, and death. Patients treated with routine intravenous bisphosphonates may not respond or may relapse on therapy. Denosumab, a monoclonal human antibody which binds to RANKL, inhibits the osteoclast-mediated bone resorption and hypercalcemia. We report a case of hypercalcemia in a patient with metastatic carcinoma breast refractory to bisphosphonate therapy responding to denosumab and to the best of our knowledge is the first reported case in Indian literature.

Authors and Affiliations

Vishal V Ramteke, Sudhir R Dash, Shubhadeep Bose, Ritu Jain

Keywords

Related Articles

Addition of Fentanyl to Hyperbaric Bupivacaine in spinal anesthesia for Caesarian section – effect on dose of local anesthetic and duration of postoperative analgesia – a randomized comparative study

Background: Spinal anesthesia is commonly used for the caesarian section for its reliability and ease of administration. However, it is limited by fixed duration of anesthesia, hypotension and lesser control of block hei...

Topical Diltiazem Versus Topical Glyceryl Trinitrate In The Management Of Chronic Anal Fissure

Background: Chemical sphincterotomy is a novel way for treating patients of chronic anal fissure which avoids the risk of fecal incontinence associated with traditional surgical methods. Aims and objectives: The aim of...

Collection and Transport of Blood

Blood cultures are collected from patients with suspected sepsis or bacteremia and are essential in the diagnosis and treatment of the etiologic agent of septicemia.

Denosumab For The Treatment Of Bisphosphonate-Refractory Hypercalcemia Of Malignancy - A Case Report

Hypercalcemia of malignancy caused primarily by tumor-induced bone resorption may lead to renal failure, coma, and death. Patients treated with routine intravenous bisphosphonates may not respond or may relapse on therap...

Transatrial-Transpulmonary correction of TOF with CMR as a definitive diagnostic tool: Replacement of conventional cardioangiography

INTRODUCTION: The objective of this study was to evaluate the associated cardiac anomalies, coronary and pulmonary artery abnormalities and aortopulmonary collaterals in patients of TOF with preoperative CMR and to corre...

Download PDF file
  • EP ID EP432588
  • DOI -
  • Views 33
  • Downloads 0

How To Cite

Vishal V Ramteke, Sudhir R Dash, Shubhadeep Bose, Ritu Jain (2015). Denosumab For The Treatment Of Bisphosphonate-Refractory Hypercalcemia Of Malignancy - A Case Report. Journal of Medical Sciences, 18(2), 153-155. https://europub.co.uk/articles/-A-432588